United States · 
Who invested in Delix Therapeutics?
Delix Therapeutics's investors include Gaingels, RA Capital Management, Artis Ventures (AV) and Presight Capital.
United States · Series B startup
Who invested in Delix Therapeutics
Funding summaryUpdated 26 Oct 2026
$25Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $25MSept 2025
- Investors
- 4
The rounds
- Sept 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 5 firms list Delix Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Delix Therapeutics
How much has Delix Therapeutics raised?
Delix Therapeutics has raised $25M across 1 round since 2025.
When did Delix Therapeutics last raise?
Delix Therapeutics's most recent round was a Series B of $25M in Sept 2025.
What was Delix Therapeutics's biggest round?
Its most recent round, $25M in Sept 2025, is also its largest on record.
Who backed Delix Therapeutics first?
Delix Therapeutics's first round on record, in Sept 2025, was backed by Gaingels, RA Capital Management and Artis Ventures (AV) and 1 others.
What stage is Delix Therapeutics at?
Delix Therapeutics's latest named round is a Series B, in Sept 2025.
Where is Delix Therapeutics based?
Delix Therapeutics is based in the United States.
Companies like Delix Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.